+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Immunotoxins"

From
From
From
Global Cancer Monoclonal Antibodies Market & Clinical Trial Insight 2024 - Product Thumbnail Image

Global Cancer Monoclonal Antibodies Market & Clinical Trial Insight 2024

  • Clinical Trials
  • November 2018
  • 1100 Pages
  • Global
From
Drug Delivery in Cancer - Technologies, Markets & Companies - Product Thumbnail Image

Drug Delivery in Cancer - Technologies, Markets & Companies

  • Report
  • November 2021
  • 747 Pages
  • Global
From
Immunotoxin Market (2021 - 2026) - Product Thumbnail Image

Immunotoxin Market (2021 - 2026)

  • Report
  • December 2020
  • 98 Pages
  • Global
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Immunotoxins are a type of immune disorder drug that combines a toxin with an antibody or other targeting molecule to specifically target and destroy cells associated with an immune disorder. They are used to treat a variety of conditions, including cancer, autoimmune diseases, and infectious diseases. Immunotoxins are designed to target and destroy cells that are resistant to traditional treatments, such as chemotherapy and radiation. They are also used to reduce the side effects of other treatments. Immunotoxins are typically administered intravenously or intratumorally, and can be used in combination with other treatments. They are generally well-tolerated and have few side effects. However, they can be expensive and may not be available in all countries. Companies in the immunotoxins market include ImmunoGen, Inc., Seattle Genetics, Inc., and Merck KGaA. Show Less Read more